# Hinge Health, Inc.: overview HNGE · NYSE · CIK 1673743 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hnge.md) · [Financials](/companies/hnge/financials.md) · [Filings](/companies/hnge/filings.md) · [Insiders](/companies/hnge/insiders.md) Latest reported revenue: [$212.8m](/filings/0001628280-26-054327.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054327). ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [101](/filings/0001193125-25-272353.md) | [117 d](/filings/0001628280-26-013808.md) | [124](/filings/0001628280-26-032224.md) | [139](/filings/0001628280-26-054327.md) | [154](/filings/0001193125-25-272353.md) | [171 d](/filings/0001628280-26-013808.md) | [182](/filings/0001628280-26-032224.md) | [213](/filings/0001628280-26-054327.md) | | Gross margin | % | [78.8%](/filings/0001193125-25-272353.md) | [81.9% d](/filings/0001628280-26-013808.md) | [80.9%](/filings/0001628280-26-032224.md) | [70.3%](/filings/0001628280-26-054327.md) | [81.8%](/filings/0001193125-25-272353.md) | [84.4% d](/filings/0001628280-26-013808.md) | [84.6%](/filings/0001628280-26-032224.md) | [86.4%](/filings/0001628280-26-054327.md) | | Operating margin | % | [(3.8%)](/filings/0001193125-25-272353.md) | [17.8% d](/filings/0001628280-26-013808.md) | [10.6%](/filings/0001628280-26-032224.md) | [(417.5%)](/filings/0001628280-26-054327.md) | [(4.0%)](/filings/0001193125-25-272353.md) | [16.0% d](/filings/0001628280-26-013808.md) | [17.6%](/filings/0001628280-26-032224.md) | [19.0%](/filings/0001628280-26-054327.md) | | Net margin | % | [0.3%](/filings/0001193125-25-272353.md) | [23.1% d](/filings/0001628280-26-013808.md) | [13.8%](/filings/0001628280-26-032224.md) | [(413.8%)](/filings/0001628280-26-054327.md) | [(1.2%)](/filings/0001193125-25-272353.md) | [18.8% d](/filings/0001628280-26-013808.md) | [19.3%](/filings/0001628280-26-032224.md) | [20.5%](/filings/0001628280-26-054327.md) | | Diluted EPS | $ per share | [0.01](/filings/0001193125-25-272353.md) | not reported | [1.31](/filings/0001628280-26-032224.md) | [(13.10)](/filings/0001628280-26-054327.md) | [(0.02)](/filings/0001193125-25-272353.md) | not reported | [0.41](/filings/0001628280-26-032224.md) | [0.52](/filings/0001628280-26-054327.md) | | Free cash flow | $m | [28.1 d](/filings/0001193125-25-272353.md) | [38.2 d](/filings/0001628280-26-013808.md) | [4.9](/filings/0001628280-26-032224.md) | [20.0 d](/filings/0001628280-26-054327.md) | [82.3 d](/filings/0001193125-25-272353.md) | [63.5 d](/filings/0001628280-26-013808.md) | [43.0](/filings/0001628280-26-032224.md) | [101 d](/filings/0001628280-26-054327.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | | Revenue | $m | [293](/filings/0001628280-26-013808.md) | [390](/filings/0001628280-26-013808.md) | [588](/filings/0001628280-26-013808.md) | | Gross margin | % | [66.3%](/filings/0001628280-26-013808.md) | [76.8%](/filings/0001628280-26-013808.md) | [79.6%](/filings/0001628280-26-013808.md) | | Operating margin | % | [(44.6%)](/filings/0001628280-26-013808.md) | [(8.2%)](/filings/0001628280-26-013808.md) | [(92.9%)](/filings/0001628280-26-013808.md) | | Net margin | % | [(36.9%)](/filings/0001628280-26-013808.md) | [(3.1%)](/filings/0001628280-26-013808.md) | [(89.9%)](/filings/0001628280-26-013808.md) | | Diluted EPS | $ per share | [(8.31)](/filings/0001628280-26-013808.md) | [(0.88)](/filings/0001628280-26-013808.md) | [(7.77)](/filings/0001628280-26-013808.md) | | Free cash flow | $m | [(65.9)](/filings/0001628280-26-013808.md) | [48.0](/filings/0001628280-26-013808.md) | [171](/filings/0001628280-26-013808.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hnge/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $296.3m | 3,570,131 | | Added +2,662,626 | | [11.2 Capital Management, LLC](/funds/2072160.md) | 2026-06-30 | $204.6m | 2,464,657 | | Reduced −1,239,867 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $178.1m | 2,146,032 | | Added +735,345 | | [Deer Management Co. LLC](/funds/1494127.md) | 2026-06-30 | $158.4m | 1,908,707 | | Reduced −725,000 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $157.1m | 1,892,834 | | Added +654,261 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $150.1m | 1,807,895 | | Added +1,424,016 | | [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $142.1m | 1,712,507 | | Added +57,309 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $134.0m | 1,613,901 | | Added +624,312 | | [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $131.1m | 1,579,056 | | Added +620,523 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $117.7m | 1,418,317 | | Added +861,186 | ## Recent filings [All 288 filings](/companies/hnge/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-21 | 20:26 ET | [8-K](/filings/0001628280-26-058439.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-058439 | | 2026-08-06 | 20:14 ET | [10-Q](/filings/0001628280-26-054327.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054327 | | 2026-08-04 | 20:08 ET | [8-K](/filings/0001628280-26-052558.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052558 | | 2026-06-09 | 20:06 ET | [8-K](/filings/0001628280-26-041886.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-041886 | | 2026-06-04 | 20:19 ET | [8-K](/filings/0001628280-26-040802.md) | 5.07 Shareholder vote results | 0001628280-26-040802 | | 2026-05-07 | 20:33 ET | [10-Q](/filings/0001628280-26-032224.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032224 | | 2026-05-05 | 20:06 ET | [8-K](/filings/0001628280-26-030499.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-030499 | | 2026-04-17 | 12:04 ET | [DEF 14A](/filings/0001628280-26-025602.md) | Proxy statement, period 2026-06-03 | 0001628280-26-025602 | | 2026-03-17 | 20:06 ET | [8-K](/filings/0001628280-26-018710.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-018710 | | 2026-03-03 | 21:11 ET | [10-K](/filings/0001628280-26-013808.md) | Annual report, period 2025-12-31 | 0001628280-26-013808 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-013808.md), filed Mar 3, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/91e9e5d2-c010-432c-8c2f-a6aad3ddf3c0) ## About the filer - CIK: 1673743 - Tickers: HNGE - Exchange: NYSE - SIC code: 7374 Services-Computer Processing & Data Preparation - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.